-
-
-
-
-
-
-
Jones Trading Reiterates Buy Rating on TriSalus Life Sciences, Inc. (TLSI) following earnings
-
-
-
-
-
-
-
TriSalus publishes thyroid embolization study results
-
-
-
-
-
-
-
Northland Reiterates Outperform Rating on TriSalus Life Sciences, Inc. (TLSI)
-
-
-
-
-
-
-
TriSalus Life Sciences, Inc. (TLSI) PT Lowered to $11 at Canaccord Genuity
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on TriSalus Life Sciences, Inc. (TLSI)
423,328 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

